Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving Q2W chemotherapy regimen: A systematic review of efficacy, effectiveness, and safety (20190355) (Pegfilgrastim in Q2W regimen: A systematic review)

16/11/2019
07/12/2020
EU PAS number:
EUPAS31967
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

01.02.06 Public Redacted Protocol Ver 1.0 2019-10-08 English

English (332.83 KB - PDF) View document
Study results
Study results

20190355_Observational Research Study Report Published Report_Redacted

English (354.02 KB - PDF) View document
Study report
Other information